The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
Najdat BazarbashiKeerat AhujaMohamed M GadYasser M SammourManpreet KaurAntonette KarrthikAnas M SaadShameer KhubberKamalpreet DhaliwalStephanie L MickJose L NaviaRishi PuriGrant W ReedAmar KrishnaswamySamir R KapadiaPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Single 6F ProGlide use for preclosure is a safe strategy for TF TAVR using the S3 valve. Additional closure device was not needed in almost one-quarter of the patients. When necessary, residual bleeding can be controlled with the AngioSeal Device at the end of the procedure. This single device preclose strategy can help to reduce the cost of TAVR procedure without increasing risk.
Keyphrases
- aortic valve
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- ejection fraction
- end stage renal disease
- minimally invasive
- chronic kidney disease
- left ventricular
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- atrial fibrillation
- patient reported outcomes
- mitral valve
- coronary artery disease